Effects of Human Mesenchymal Stem Cells Isolated from Wharton's Jelly of the Umbilical Cord and Conditioned Media on Skeletal Muscle Regeneration Using a Myectomy Model

Skeletal muscle has good regenerative capacity, but the extent of muscle injury and the developed fibrosis might prevent complete regeneration. The in vivo application of human mesenchymal stem cells (HMSCs) of the umbilical cord and the conditioned media (CM) where the HMSCs were cultured and expanded, associated with different vehicles to induce muscle regeneration, was evaluated in a rat myectomy model. Two commercially available vehicles and a spherical hydrogel developed by our research group were used. The treated groups obtained interesting results in terms of muscle regeneration, both in the histological and in the functional assessments. A less evident scar tissue, demonstrated by collagen type I quantification, was present in the muscles treated with HMSCs or their CM. In terms of the histological evaluation performed by ISO 10993-6 scoring, it was observed that HMSCs apparently have a long-term negative effect, since the groups treated with CM presented better scores. CM could be considered an alternative to the in vivo transplantation of these cells, as it can benefit from the local tissue response to secreted molecules with similar results in terms of muscular regeneration. Searching for an optimal vehicle might be the key point in the future of skeletal muscle tissue engineering.

[1]  T. Pereira,et al.  Effects of umbilical cord tissue mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration after neurotmesis injuries , 2014, Journal of stem cells & regenerative medicine.

[2]  S. Torihashi,et al.  Transplantated Mesenchymal Stem Cells Derived from Embryonic Stem Cells Promote Muscle Regeneration and Accelerate Functional Recovery of Injured Skeletal Muscle , 2013, BioResearch open access.

[3]  A. Maurício,et al.  Biological evaluation of alginate-based hydrogels, with antimicrobial features by Ce(III) incorporation, as vehicles for a bone substitute , 2013, Journal of Materials Science: Materials in Medicine.

[4]  M. Lopes,et al.  Development and characterization of novel alginate-based hydrogels as vehicles for bone substitutes. , 2013, Carbohydrate polymers.

[5]  T. Pereira,et al.  Biomaterials and Stem Cell Therapies for Injuries Associated to Skeletal Muscular Tissues , 2013 .

[6]  T. Pereira,et al.  Mesenchymal Stem Cells from Extra-Embryonic Tissues for Tissue Engineering – Regeneration of the Peripheral Nerve , 2013 .

[7]  D. Peterson,et al.  Human Mesenchymal Stem Cell Grafts Enhance Normal and Impaired Wound Healing by Recruiting Existing Endogenous Tissue Stem/Progenitor Cells , 2013, Stem cells translational medicine.

[8]  G. Hoser,et al.  Restricted Myogenic Potential of Mesenchymal Stromal Cells Isolated from Umbilical Cord , 2012, Cell transplantation.

[9]  R. Tuan,et al.  Mesenchymal stem cell therapy for attenuation of scar formation during wound healing , 2012, Stem Cell Research & Therapy.

[10]  M. Wiberg,et al.  Fibrin conduit supplemented with human mesenchymal stem cells and immunosuppressive treatment enhances regeneration after peripheral nerve injury , 2012, Neuroscience Letters.

[11]  A. Varejão,et al.  Cellular Systems and Biomaterials for Nerve Regeneration in Neurotmesis Injuries , 2011 .

[12]  V. Tkachuk,et al.  Mesenchymal Stem Cells in Tissue Growth and Repair , 2011, Acta naturae.

[13]  A. Salgado,et al.  Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. , 2011, Current stem cell research & therapy.

[14]  G. Pins,et al.  Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. , 2011, Tissue engineering. Part A.

[15]  Biju Parekkadan,et al.  Mesenchymal stem cells as therapeutics. , 2010, Annual review of biomedical engineering.

[16]  T. Walters,et al.  Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. , 2010, Tissue engineering. Part A.

[17]  Amir Toren,et al.  The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. , 2009, Cytotherapy.

[18]  F. Bonilla-musoles,et al.  Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. , 2009, Fertility and sterility.

[19]  T. Silveira,et al.  The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis. , 2009, Journal of pediatric surgery.

[20]  Yao Zhang,et al.  Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure , 2009, Molecular Biology Reports.

[21]  Jeffrey M Karp,et al.  Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.

[22]  S Geuna,et al.  Use of hybrid chitosan membranes and N1E-115 cells for promoting nerve regeneration in an axonotmesis rat model. , 2008, Biomaterials.

[23]  M. Hincke,et al.  Fibrin: a versatile scaffold for tissue engineering applications. , 2008, Tissue engineering. Part B, Reviews.

[24]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[25]  George Q. Daley,et al.  Prospects for Stem Cell-Based Therapy , 2008, Cell.

[26]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[27]  A. Marcus,et al.  Fetal stem cells from extra-embryonic tissues: do not discard , 2008, Journal of cellular and molecular medicine.

[28]  C. Zhang,et al.  Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells , 2007, Acta Pharmacologica Sinica.

[29]  Stefanie Dimmeler,et al.  Cell-Based Therapy of Myocardial Infarction , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Z. Popović,et al.  SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Massimo Franchini,et al.  Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. , 2006, Bone.

[32]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[33]  K. Schaser,et al.  Autologous bone marrow-derived cells enhance muscle strength following skeletal muscle crush injury in rats. , 2006, Tissue engineering.

[34]  M. Ko,et al.  Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton's Jelly to Dopaminergic Neurons In Vitro: Potential Therapeutic Application for Parkinsonism , 2006, Stem cells.

[35]  O. Ringdén,et al.  Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  Dolores Baksh,et al.  Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors , 2005, Stem cells.

[37]  Chun-Chieh Huang,et al.  Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord , 2004, Stem cells.

[38]  Freddie H. Fu,et al.  Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis , 2003, Muscle & nerve.

[39]  L Sedel,et al.  A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. , 2003, Biomaterials.

[40]  Yong Li,et al.  Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. , 2002, The American journal of pathology.

[41]  L. Messina,et al.  Gelatin–thrombin-based Hemostatic Sealant for Intraoperative Bleeding in Vascular Surgery , 2002, Annals of vascular surgery.

[42]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[43]  G. Hoser,et al.  Myogenic potential of mesenchymal stem cells - the case of adhesive fraction of human umbilical cord blood cells. , 2013, Current stem cell research & therapy.

[44]  Todd C McDevitt,et al.  Stem cell paracrine actions and tissue regeneration. , 2010, Regenerative medicine.

[45]  Freddie H. Fu,et al.  Stem cells for the treatment of skeletal muscle injury. , 2009, Clinics in sports medicine.

[46]  Lorenzo Moroni,et al.  Tissue engineering – an introduction , 2008 .

[47]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[48]  Freddie H. Fu,et al.  Growth factors improve muscle healing in vivo. , 2000, The Journal of bone and joint surgery. British volume.